搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
太平洋号 on MSN
22 小时
美国IBD经销商代表团莅临爱玛科技集团,共谋合作新篇章
天津2024年12月23日 /美通社/ -- 2024年12月7日,爱玛科技集团盛情邀请来自美国的知名IBD经销商代表团至总部参观。同时随行的还有爱玛美国子公司AIMA EBIKE的CEO Angela ...
2 天
This IBD 50 China Stock Climbs Back 58%, Hits Buy Point
This China stock hit a buy point of an erratic base. The EV stock has recovered from a sell-off and reached a new high.
Investor's Business Daily on MSN
1 天
TSMC, Tradeweb And Another IBD 50 Name Struggle With Breakouts
And a handful of IBD 50 names, including Tradeweb Markets, Taiwan Semiconductor Manufacturing — also known as TSMC stock — ...
腾讯网
4 天
中山六院左涛课题组揭示肠道噬菌体移植可缓解炎症性肠病间发性 ...
Science & Technology近日,我院左涛研究员和高翔主任医师团队合作在Gut(IF=23.0)在线发表题为“Fecal phageome transplantation alleviates intermittent ...
4 天
Nvidia, IBD Stock Of The Day, Offers Early Buy Point As It Crosses Key Levels
Nvidia is IBD Stock Of The Day as the AI chipmaker rises above its 50-day moving average and a downward-sloping trendline.
腾讯网
11 天
近半溃疡性结肠炎患者达缓解!赛诺菲/梯瓦潜在“best-in-class”疗法 ...
Duvakitug(曾用名TEV’574)是一款潜在“best-in-class”的人源IgG1-λ2单抗,靶向TL1A,又称肿瘤坏死因子(TNF)超家族成员15。TL1A通过与其受体DR3结合,可放大炎症反应并加速IBD相关纤维化的进展。靶向TL1 ...
11 天
on MSN
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...
Investor's Business Daily on MSN
1 天
Wix.com, IBD Stock Of The Day, Pivots To Interactive AI Products
Wix.com is the IBD Stock Of The Day amid the website builder's 81% share gain in 2024. Strong institutional support is a ...
biopharma-reporter
11 天
Teva and Sanofi’s IBD drug hits Phase 2 targets
The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...
FierceBiotech
11 天
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in ...
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
rheumatologyadvisor
5 天
Post-Transplant Outcomes Among Patients With IBD or PSC Improve With Advanced Therapies
Patients with inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) show promising outcomes when receiving ...
9 天
on MSN
IBD vs SD Champion Ka Tashan: Yo Yo Honey Singh interrupts Remo's challenge, 'I don’t ...
In a thrilling episode of India’s Best Dancer vs Super Dancer: Champion Ka Tashan, Yo Yo Honey Singh interrupts a dance ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈